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Advanced maturation of human cardiac tissue 
grown from pluripotent stem cells
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Diogo teles1,3,4, Masayuki Yazawa2 & Gordana Vunjak-Novakovic1,5*
Cardiac tissues generated from human induced pluripotent stem 
cells (iPSCs) can serve as platforms for patient-specific studies of 
physiology and disease1–6. However, the predictive power of these 
models is presently limited by the immature state of the cells1,2,5,6. 
Here we show that this fundamental limitation can be overcome 
if cardiac tissues are formed from early-stage iPSC-derived 
cardiomyocytes soon after the initiation of spontaneous contractions 
and are subjected to physical conditioning with increasing intensity 
over time. After only four weeks of culture, for all iPSC lines 
studied, such tissues displayed adult-like gene expression profiles, 
remarkably organized ultrastructure, physiological sarcomere 
length (2.2 µm) and density of mitochondria (30%), the presence of 
transverse tubules, oxidative metabolism, a positive force–frequency 
relationship and functional calcium handling. Electromechanical 
properties developed more slowly and did not achieve the stage of 
maturity seen in adult human myocardium. Tissue maturity was 
necessary for achieving physiological responses to isoproterenol and 
recapitulating pathological hypertrophy, supporting the utility of 
this tissue model for studies of cardiac development and disease.
Even the best available methods have limited ability to emulate 
the physiology of adult myocardium1–12; excitation–contraction 
coupling (requiring transverse tubules (T-tubules)), positive force–
frequency relationship (requiring mature calcium handling) and effi-
cient energy conversion (requiring oxidative metabolism) are notably 
absent2,3,5,6,8–10. Adult ventricular myocytes are uniquely organized for 
beating function, having densely packed sarcomeres, mitochondria, 
transverse tubules and sarcoplasmic or endoplasmic reticulum (SR/ER). 
Their mitochondria are positioned adjacent to sarcomeres and 
calcium pumps to enhance ATP diffusion; the sarcoplasmic reticulum 
provides fast delivery of stored calcium ions to contractile proteins; and 
the T-tubules synchronize heartbeats by concentrating L-type calcium 
channels, which are positioned close to the ryanodine receptors that 
release calcium ions from the SR/ER13. This highly specialized machin-
ery for excitation–contraction coupling is not present in the fetal heart, 
but emerges after birth14 with the switch from glycolytic to oxidative 
metabolism that supports the energy demands of the postnatal heart15.
Human iPSC-derived cardiomyocytes (hiPS-CMs) can be matured 
by long-term culture and electrical, hydrodynamic and mechanical 
stimulation8,9,12,16–18. Recent studies have indicated that this in vitro 
maturation may not follow the in vivo developmental paradigm; high 
stimulation frequencies benefit maturation in vitro9, whereas the 
native heart beats more slowly following birth5,14. We investigated 
the reasons why current strategies fail to develop the characteristics 
of adult myocardium. Because the responsiveness of hiPS-CMs to 
physical stimuli declines as differentiation progresses, we suggested 
that electromechanical conditioning should be initiated early, during 
the period of high cell plasticity. As the heart matures in response to 
energy demands, we further hypothesized that increasing the intensity 
of induced contractions would enhance the development of mature 
ultrastructure and function.
To test these hypotheses, we studied the maturation of human cardiac 
tissues grown from early-stage hiPS-CMs (day 12, immediately follow-
ing the first spontaneous contractions) or late-stage hiPS-CMs (day 28, 
matured in culture). Cardiac tissues were assembled in a modular tissue 
platform that enabled individual control of the culture environment 
and physical signalling. hiPS-CMs (derived from three donors) and 
supporting fibroblasts were incorporated into fibrin hydrogel stretched 
between two flexible pillars (designed to provide mechanical forces 
similar to those in native myocardium) and subjected to electrical stim-
ulation to induce auxotonic contractions. Three conditioning regimes 
were applied: (i) control (no stimulation); (ii) constant (three weeks at 
2 Hz); and (iii) intensity training (two weeks at a frequency increasing 
from 2 Hz to 6 Hz by 0.33 Hz per day, followed by one week at 2 Hz. 
The resulting tissues were 6 mm long and 1.8 mm in diameter, and 
were evaluated in real time (for contractile and conductive behaviour 
and calcium handling) and by end-point assays (for gene expression, 
proteins and ultrastructure), using human fetal cardiac tissues (FCTs) 
and adult human heart ventricles as benchmarks (Fig. 1a, Extended 
Data Fig. 1a–e). Intensity-trained tissues grown from early-stage 
hiPS-CMs (hereafter early-stage intensity-trained) exhibited compact 
and well-differentiated cardiac muscle (Extended Data Fig. 1f–p) and 
marked changes in the expression of genes associated with adult-like 
conduction (increased ITPR3, KCNH2, decreased HCN4), maturation 
(increased NPPB, MAPK1, PRKACA), ultrastructure (increased MYH7, 
GJA1, TNNI3, AKAP6, GJA5, JPH2), energetics (increased AKAP1, 
TFAM, PPARGC1A) and calcium handling (increased CAV3, BIN1, 
ATP2A2, RYR2, ITPR3). The other early-stage-derived tissues, all late-
stage-derived tissues and FCTs displayed immature cardiac phenotypes 
(Fig. 1b, Extended Data Fig. 2a, b).
Seeding with early-stage hiPS-CMs was critical for the response of 
the mature tissues to physical signals. Only the early-stage intensity- 
trained tissues displayed orderly signal propagation and anisotropic 
gap junctions. Among all tested groups, early-stage intensity-trained 
tissues had electrophysiological properties that were comparable to 
Biowires9, including the shape of the action potential with its char-
acteristic notch, the resting membrane potential of −70.0 ± 2.7 mV, 
the IK1 current (peak inward density of –9.9 ± 3.8 pA pF−1 and 
peak outward density of 0.30 ± 0.12 pA pF−1) and the conduction 
velocity (25.0 ± 0.9 cm s−1) (Fig. 1c, d, Extended Data Figs. 2, 3a–f, 
Supplementary Videos 1, 2).
Early-stage intensity-trained tissues also exhibited a positive force–
frequency relationship (FFR), a hallmark of maturation not seen in 
other in vitro myocardial tissue models5,6. The generated forces mark-
edly exceeded those in all other tested groups and FCT (Fig. 1f), but 
remained below those in adult myocardium19 (44 mN mm−2). Directly 
measured forces and contraction amplitudes increased approximately 
twofold over the range of stimulation frequencies (1–6 Hz) during 
the maturation of early-stage intensity-trained tissues, indicating the 
maturation of contractile behaviour. These tissues acquired regular 
contraction profiles, in contrast to late-stage intensity-trained tissues 
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(Extended Data Figs. 3g–i, 4a–d, Supplementary Videos 1, 2). The sur-
rogate measurements of force from calcium recordings in early-stage 
intensity-trained tissues (Extended Data Fig. 3j, k), were consistent with 
the direct force measurements.
Cell populations were dominated by cardiomyocytes, and the 
MLC2v+:MLC2a+ ratio, an indicator of cardiomyocyte maturity, 
depended on the stimulation regime and developmental stage of 
hiPS-CMs. The increasing contractile demands induced the adult-like 
cardiac morphology that is necessary for high force generation in early- 
stage intensity-trained tissues. The cell size increased (an indicator 
of physiological hypertrophy8) and both cells and nuclei were elon-
gated (an indicator of maturation8). The sarcomere length reached 
2.2 µm, a similar value to that of adult human ventricular myocytes8. 
The contractile capacity, fraction of cells containing sarcomeres and 
Fig. 1 | Intensity training of cardiac tissues derived from early-stage 
hiPS-CMs enhances maturation. a, Experimental design: early-stage 
or late-stage hiPS-CMs and supporting fibroblasts were encapsulated 
in fibrin hydrogel to form tissues stretched between two elastic pillars 
and made to contract by electrical stimulation. Gradual increase in 
frequency of stimulation to supra-physiological levels (intensity regime) 
was compared to stimulation at constant frequency (constant regime), 
unstimulated controls and human adult and fetal heart ventricles. b, Gene 
expression data for six groups of cardiac tissues, and adult and fetal heart 
ventricles. c, Action potential for the early-stage intensity-trained  
group. d, IK1 current–voltage (I–V) curves (mean ± s.d.). e, Early-stage  
intensity-trained tissues from all three iPSC lines (C2A, WTC11, 
IMR90), but not the other groups, developed a positive force–frequency 
relationship after four weeks of culture. Line above graph indicates 
P < 0.05 for the 2–6 Hz group versus other training regimes using  
two-way ANOVA followed by Tukey’s honest significant difference (HSD) 
test. f, Cell area over time. Line above graph indicates P < 0.05 versus other 
timepoints using two-way ANOVA followed by Tukey’s HSD test; *P < 0.05 
versus control group using one-way ANOVA followed by Tukey’s HSD test. 
Data in e and f are mean ± 95% confidence interval (CI). Sample sizes are 
shown in Supplementary Information, ‘Main figure data sample sizes’.
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organization of sarcomeric α-actinin also resembled those of adult 
human myocardium (Fig. 1e, Extended Data Figs. 4e–k, 5).
Ultrastructural development was dependent on the stimulation 
regime and the developmental stage of hiPS-CMs from which the tis-
sues were derived. Only early-stage intensity-trained tissues displayed 
orderly registers of sarcomeres with I-bands, A-bands, M lines, Z 
lines, desmosomes, intercalated discs, a high density of mitochondria 
positioned adjacent to the contractile machinery and proteins organ-
ized for increased energetics (Fig. 2a, b, Extended Data Figs. 6, 7a, b).
Whereas the fetal heart favours glucose as the primary energy sub-
strate19, the increased workload in the postnatal heart results in mature 
mitochondria that are optimized for fatty acid oxidation20,21. The per cent 
area of mitochondria in early-stage intensity-trained tissues (30 ± 2.9%) 
was similar to those measured in adult human myocardium22,23. Active 
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Fig. 2 | Enhanced cardiac ultrastructure, bioenergetics and T-tubule 
formation in early-stage intensity-trained tissues derived from C2A 
cells. a, Transmission electron microscopy (TEM) of tissues and cardiac 
tissue models. Scale bars, 1 µm. b, d, g–k, Early-stage intensity-trained 
tissues cultured for four weeks and derived from C2A cells. b, Registers 
of sarcomeres, showing A-bands, I-bands, M lines, Z lines, sarcoplasmic 
reticulum (SR) and T-tubules (TT). Scale bar, 1 µm. c, Density of 
mitochondria; shaded area represents range of values measured in adult 
human heart. Line above graph indicates P < 0.05 versus other training 
regimes using two-way ANOVA followed by Tukey’s HSD test. d, Lipid 
droplets (red asterisk). Scale bar, 1 µm. e, Oxygen consumption rate 
(OCR). Oligo, oligomycin; FCCP, carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone; Rtn/AA, rotenone and antimycin A. f, Extracellular 
acidification rate. 2-DG, 2-deoxyglucose. g–i, Cross-sections taken to 
evaluate T-tubules: bright field view (g; scale bar, 500 µm); T-tubules 
(h, i; green, WGA; red, cardiac troponin T (cTnT); blue, nuclei; scale bar, 
10 µm). j, Calcium handling ultrastructure. Scale bar, 15 µm. k, Regular 
spacing of calcium handling proteins shown in j. AU, arbitrary units. 
Data are mean ± 95% CI; sample sizes are shown in Supplementary 
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biogenesis24 was associated with the production of phospholipids near 
the sarcomeres, a switch to oxidative metabolism and the formation of 
T-tubules (Fig. 2c–f, Extended Data Fig. 7c, d).
Early-stage intensity-trained tissues contained robust T-tubules, both 
longitudinally and in cross-sections. T-tubules (measured using wheat 
germ agglutinin (WGA) and di-8-ANEPPS) were co-localized with 
the bridging integrator 1 (BIN1), ryanodine receptor 2 (RYR2), and 
L-type calcium channels (CaV1.2, encoded by CACNA1C) with spacing 
optimized for calcium handling (Fig. 2g–k, Extended Data Fig. 8), as 
in the adult heart25. These tissues displayed spatially uniform cell den-
sities, presumably owing to the enhanced transport of nutrients and 
metabolites during tissue contractions, generated the highest force, and 
expressed the Ca2+-induced Ca2+ release (CICR) modulators RYR2 
(control of SR/ER calcium release) and BIN1 (control of ion flux along 
T-tubules26) (Fig. 3a, Extended Data Figs. 8a, f, g, 9a).
The frequency-dependent acceleration of relaxation (FDAR), an 
intrinsic property of adult myocardium that was observed for early- 
stage intensity-trained tissues showed that the tissues subjected to 
supra-threshold electrical pacing regimes developed mechanisms to 
respond to the increasing workload. The presence of ultrastructural 
machinery for contraction–relaxation was confirmed by the position-
ing of T-tubules in proximity to the cardiac calcium pump SERCA2A 
(encoded by ATP2A2) and the sodium–calcium exchanger NCX1 
(encoded by SLC8A1). Consistently, transcription of the genes respon-
sible for clearing cytosolic calcium (ATP2A2 and SLC8A118) increased 
over time, and the sequestration and extrusion of calcium became faster, 
enabling the hiPS-CMs to relax and respond to contractile triggers. 
Blocking CaV1.2 with nifedipine or verapamil gradually reduced calcium 
transients in a training-dependent manner, while the response to caffeine 
indicated that only the early-stage intensity-trained tissues had func-
tional intracellular calcium stores. Blocking SERCA with thapsigargin 
treatment to prevent SR/ER calcium uptake halted calcium transients, 
indicating that they are dependent on a functional sarcoplasmic retic-
ulum. Subsequent addition of caffeine had no effect, consistent with 
calcium depletion of the SR/ER (Fig. 3b–d, Extended Data Fig. 9b–h).
Post-rest potentiation confirmed the functionality of SR/ER calcium 
stores in early-stage intensity-trained tissues. None of the other tested 
tissues responded to increased calcium levels or developed calcium alter-
nans, owing to the lack of T-tubules and inefficient coupling between 
intracellular calcium entry and release. When CICR was blocked 
with ryanodine to test RYR2 function, only early-stage intensity- 
trained tissues showed a response, probably owing to the presence of 
T-tubules, which are necessary for CICR. Notably, the positive FFR 
was blunted by ryanodine treatment, and completely reversed when 
calcium sequestration by SERCA2a was blocked with thapsigargin, 
indicating the importance of both CICR and the reuptake of calcium 
into the sarcoplasmic reticulum (Fig. 3e, Extended Data Fig. 9i–k).
Because a functional β-adrenergic receptor system is dependent on 
both intracellular calcium reserves and the proximity of CaV1.2 channels 
and T-tubules4,26,27, comprehensive responses to β-adrenergic agonists 
are an indicator of phenotypic maturation28. We investigated whether 
early-stage intensity-trained tissues had an ionotropic response to iso-
proterenol, since this effect is not seen in current in vitro cardiac tissue 
models2,10. We detected positive chronotropic, ionotropic and lusitropic 
responses to isoproterenol in early-stage intensity-trained tissues, with 
EC50 (half-maximum effective concentration) values corresponding to 
those observed in clinical studies29 (Fig. 3f–h, Extended Data Fig. 10a, b).
Tissue maturity was necessary to recapitulate critical aspects of car-
diac hypertrophy (HCM), a leading cause of sudden cardiac death in 
athletes2. As expected, hypertrophic tissues displayed decreased beat-
ing frequency and increased durations of intracellular calcium tran-
sients and decay times relative to healthy controls, and were not able to 
electromechanically capture when stimulated at high frequencies. The 
onset of HCM diminished the FDAR and resulted in a negative FFR, in 
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contrast to healthy tissues. Differences between healthy and diseased 
groups were most pronounced in the intensity-trained tissues (Fig. 3i, j, 
Extended Data Fig. 10c–f).
A recent study12 reported the culture of large (7 × 7 mm2 to 
36 × 36 mm2) and thin (50 µm) human heart tissues, grown without 
exogenous stimulation, that displayed less developed ultrastructure, no 
evidence of oxidative metabolism, slightly negative FFR, comparable 
APD and conduction velocity, and approximately fourfold higher gen-
erated force per unit cross-sectional tissue area when compared to the 
tissues cultured here. It would be instructive to explore how the differ-
ent tissue geometries (very thin patches versus cylindrical muscle) and 
culture protocols (no external stimulation versus intensity training)12 
contributed to the measured differences in structural and functional 
tissue outcomes in comparison to the present study.
In summary, we have demonstrated that adult-like human cardiac 
tissue can be grown from hiPS-CMs in fibrin hydrogel subjected to 
stretch and auxotonic contractions in just four weeks of in vitro cul-
ture. Two methodological advances underlie the accelerated cardiac 
maturation: the formation of tissues from early-stage hiPS-CMs, which 
displayed marked plasticity immediately after the initiation of sponta-
neous contractions; and physical conditioning with increasing intensity 
(mimicking mechanical loading during the fetal–postnatal transition). 
Under these conditions, tissues developed adult-like gene expression 
and tissue ultrastructure throughout the tissue volume, oxidative 
metabolism, FDAR, positive FFR and physiological calcium handling.
A notable result of our study is that highly accelerated and extensive 
maturation of molecular, structural and metabolic features of cardiac 
tissue was associated with slower and less complete establishment of 
mature cardiac function. We have demonstrated that physiological cell 
density is not sufficient to achieve adult-like mechanical function; that 
FDAR and positive FFR can be established at subnormal levels of force 
generation; and that T-tubules and oxidative metabolism are required 
for physiological FFR and calcium handling. Our tissue model does 
not recapitulate the macroscopic structure of the myocardium, and the 
maturation period of four weeks may be too short to establish all the 
functional features of adult myocardium. These factors may contribute 
to the contrast between the impressive morphological maturation and 
the less complete functional maturation. It would therefore be instruc-
tive to use this human cardiac tissue model to study the progression of 
functional maturation.
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MEthodS
Cardiac differentiation of human iPSCs. Human induced pluripotent stem cells 
were obtained through material transfer agreements from S. Duncan, University 
of Wisconsin (C2A line), B. Conklin, Gladstone Institute (WT11 line) and M.Y., 
Columbia University (IMR90 line) and routinely checked for mycoplasma con-
tamination. iPSCs were expanded on growth-factor-reduced Matrigel-coated plates 
(Corning) in mTeSR1 medium (Stemcell Technologies) that was changed on a 
daily basis, and passaged at 85–95% confluence in a 1:6 split using Accutase (Life 
Technologies). For the first 24 h after passaging, the culture medium was supple-
mented with 5 µM Y-27632 dihydrochloride (Tocris, 1254).
Cardiac differentiation of iPSCs was initiated in confluent monolayers by 
replacing the mTeSR1medium with RPMI + B27−insulin medium, consisting of 
RPMI-1640 (Life Technologies), 1 × B27 supplement without insulin (a source of 
omega-3 fatty acids and the thyroid hormone that promotes cardiac maturation; 
Life Technologies), 100 U penicillin (Life Technologies), 0.1 mg/ml streptomy-
cin (Life Technologies) and 50 µg/ml ascorbic acid (Sigma, A4544). During the 
first 24 h, the medium was further supplemented with activin A (50 ng/ml, R&D 
Systems) and bone morphogenetic protein 4 (BMP4, 25 ng/ml, R&D systems). 
From 24–72 h, the RPMI + B27−insulin medium was supplemented with vascular 
endothelial growth factor (VEGF, 10 ng/ml, R&D systems). Beyond 72 h through 
to the end of the differentiation process (up to 12 days), RPMI + B27 medium, 
consisting of RPMI-1640, 1 × B27 supplemented with insulin (Life Technologies), 
100 U penicillin, 0.1 mg/ml streptomycin and 50 µg/ml ascorbic acid, was used and 
refreshed every two days. At day 12, the cells were characterized by flow cytom-
etry using the cardiomyocyte-specific marker cTnT (clone 13-11, NeoMarkers). 
Differentiation typically resulted in cell populations containing 80–90% cTnT+ 
cells at day 12, which were subsequently used in experiments without selection 
for cardiomyocytes.
Human fetal cardiac tissues. Fetal hearts were purchased as surgical waste from 
Advanced Bioscience Resources (Alameda, CA), and delivered on ice within 
2.5 h of surgery. Left ventricles were sectioned from the apex towards the atria 
into 7 mm long × 2 mm wide strips, washed three times in Hank’s Balanced Salt 
Solution (Gibco), transferred to low attachment six-well plates (Nunc) containing 
RPMI + B27 medium, and placed into the incubator for 1 h before taking meas-
urements. FCT strips were analysed in a similar manner to the cardiac tissues for 
contractile behaviour, force generation, gene expression, cardiac proteins, ultras-
tructure and histomorphology, as detailed below. In addition, RNA isolated from 
32 pooled fetal hearts, from gestational weeks (GW)21–37, was obtained from 
Clontech (Mountain View, CA) for gene expression studies.
Human adult heart tissue. Adult heart cDNA (Clontech, 637213 and 3 H 
Biomedical AB, SC6214) was used for measurement of gene expression. Tissue 
samples from adult left ventricles were obtained as surgical waste through an insti-
tutional review board at Columbia University.
Tissue bioreactor platform. The platform was assembled from two separate 
components: the wells for tissue culture, and an array of support structures with 
integrated elastomeric pillars for tissue attachment (1 mm in diameter, 6 mm axis-
to-axis distance). Both components were fabricated out of polycarbonate using 
a computer numerical control (CNC) milling machine with mating features for 
stability and repeatable positioning (Extended Data Fig. 1a–c).
The pillars were formed by centrifugal casting of polydimethylsiloxane (PDMS, 
Dow Corning Sylgard 184) through, and extending from, the polycarbonate sup-
port structures. The supports were first inserted into Delrin (polyoxymethylene) 
moulds fabricated by CNC machining and polydimethylsiloxane (PDMS; 10:1 
ratio of base:curing agent) was centrifugally cast at 400 relative centrifugal force 
for 5 min and cured in an oven at 60 °C for 1 h. The resulting component consisted 
of three pairs of pillars to support the formation of three tissues (Extended Data 
Fig. 1d). Pillars were 1 mm in diameter, 9 mm in length, and spaced 6 mm axis-
to-axis.
The platform contained 12 wells for tissue culture that were patterned with 
exact 48-well-plate spacing, so that the platform corresponded to one quar-
ter of the standard 48-well plate. Each well had a bottom portion measuring 
10 mm × 4 mm × 4 mm where the cells in hydrogel were introduced, and a wider 
top portion measuring 10 mm × 7 mm × 4 mm for culture medium. A glass slide 
was bonded to the bottom of the platform to enable microscopic observation.
Electrical stimulation of the cell–hydrogel tissues was performed using carbon 
rods (Ladd Research Industries) as electrodes. The carbon rods were placed into 
slots machined on each side of the culture well, aligned in parallel and positioned 
perpendicular to the long axis of both the culture well and the tissue. The elec-
trodes were connected to a cardiac stimulator (Grass s88x) by platinum wires (Ladd 
Research Industries). Electrical stimulation was generated by a spatially uniform, 
pulsatile electrical field (4.5 mV intensity, 2 ms in duration, monophasic square 
waveform) perpendicular to the long axis of the tissue. The parameter settings 
amplitude, duration, frequency and waveform were controlled by the Grass s88x 
cardiac stimulator.
Culture of cardiac tissues. Differentiated hiPS-CMs were combined with sup-
porting human dermal fibroblasts (Lonza), cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% v/v fetal bovine serum, 100 U penicil-
lin, and 0.1 mg/ml streptomycin, at a ratio of 75% hiPS-CMs and 25% fibroblasts. 
The cells were subsequently encapsulated in fibrin hydrogel by mixing 20 mg/ml 
human fibrinogen (Sigma), 100U/ml human thrombin (Sigma-Aldrich) and the 
cell suspension at a 3:1:1 ratio. The hydrogel solution (200 µl containing 2 million 
cells) was dispensed into each well of the platform and allowed to polymerize at 
37 °C for 30 min, so that the tissues readily formed around the pillars. Then, 800 µl 
of RPMI + B27 medium containing 0.2 mg/ml aprotinin (Sigma-Aldrich, A3428) 
were added into each well, with an additional 30 ml of RPMI + B27 medium con-
taining 0.2 mg/ml aprotinin (Sigma-Aldrich, A3428) added to a 100-mm Petri dish 
(Corning, 430591) containing one platform (12 tissues). Subsequently, medium 
was changed every other day: 30 ml RPMI + B27 medium containing 0.2 mg/ml 
aprotinin (Sigma-Aldrich, A3428) for the first seven days, and then 30 ml 
RPMI + B27 medium (either days 7–28 or days 7–84).
The pillars were designed to subject the tissues to mechanical loading, mim-
icking that in native human myocardium. Hydrogel compaction caused passive 
tension in the tissues as they were stretched between the two pillars, inducing 
elongation and alignment. Synchronous contractions induced by electrical stim-
ulation generated dynamic forces in the contracting tissues attached to the pillars 
that were forced to work against the load.
Electrical stimulation was initiated on day seven, using one of three training 
regimes (Fig. 1a): control (no electrical stimulation, 0 Hz), constant (constant fre-
quency of 2 Hz), and intensity training (a ramped stimulation that increased the 
frequency, from 2 Hz on day 7 to 6 Hz on day 21, by 0.33 Hz per day; tissues were 
then stimulated at 2 Hz until day 28) (Extended Data Fig. 1e). Engineered tissues 
were randomly assigned to experimental groups. Tissues were cultured for a period 
of four weeks in 16 independent experiments, using three lines of iPSCs. Samples 
sizes for the main figures are shown in Supplementary Information, ‘Main figure 
data sample sizes’.
Tissue properties were evaluated using real-time assessment of: amplitude and 
frequency of contractions, calcium handling, force generation, excitation threshold 
and maximum capture rate. End-point assays were performed to determine cell 
and tissue morphology (histologically), ultrastructure (by transmission electron 
microscopy), gene expression (using quantitative real-time PCR with reverse 
transcription (RT–PCR)) and the presence and distribution of cardiac proteins 
(immunohistochemistry).
Contractility analysis. Tissue contractility was measured by tracking the change in 
tissue area as a function of time. Live-cell, bright-field videos were acquired at rates 
of up to 150 frames per second using a Pike F-032b (Allied Vision Technologies) 
camera controlled with custom SPLASSH software25. Acquired video frames were 
inverted and an automated intensity threshold was used to identify cell location in 
the video frame. First, a baseline timepoint in the video corresponding to a relaxed 
tissue state was selected. Absolute differences in cell area from the baseline frame 
were then calculated to create a time course of cell area dynamics as a function 
of time. The resulting time courses were analysed using a native MATLAB auto-
mated peak finding algorithm to determine locations of maximum cell contraction 
indicated by the locations of local maxima in the timecourses. Beat period lengths 
were determined from the length of time between the pairs of local maxima. Beat 
frequencies were determined by inverting beat periods. Contraction amplitude 
relaxation times were measured from the length of time required for the tissue to 
relax from the peak contraction amplitude of the local maxima to the calculated 
relaxation amplitude (for example, the R90 time was the time elapsed between full 
contraction and 10% contraction).
Calcium handling. Tissues within culture platforms were loaded with Fluo-4 
NW (50% v/v, Life Technologies) in RPMI + B27 medium containing 5 µM bleb-
bistatin (Sigma) for 30 min at 37 °C as necessary to reduce movement artefacts. 
Videos were acquired at a rate of 150 frames per second using a Pike F-032 
camera (Allied Vision Technologies) as described in ‘Contractility analysis’. 
Videos were analysed in MATLAB using a custom script that calculated the 
temporal changes in calcium fluorescence intensity. Specifically, each frame was 
normalized to a baseline background region chosen by the user to give baseline- 
corrected changes in minimum and maximum fluorescence values for each 
frame. The temporal change in fluorescence intensity was presented as a cal-
cium transient trace from which the measurements were obtained. In brief, the 
calcium transient ‘timing’ was determined as the peak-to-peak values of two 
successive beats as defined by the peak maxima. Calcium transient ‘amplitude’ 
was determined by numerically integrating the area below the peak maxima 
relative to the baseline. Calcium transient traces were analysed during 5-mM- 
caffeine stimulation of tissues previously treated with either 1 mM verapamil 
(Sigma-Aldrich) or 1 µM thapsigargin (Sigma-Aldrich). Caffeine responses were 
quantified by comparing this calcium transient amplitude before and after the 
addition of 5 mM caffeine (Sigma-Aldrich).
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Conduction velocity. A surrogate of conduction velocity was assessed by calcium 
propagation within the entire tissues that were pre-treated with 5 µM blebbistatin 
(Sigma-Aldrich) to uncouple true Ca2+-dependent fluorescent motion from the 
fluorescent signals caused by motion artefacts. The conduction velocity was calcu-
lated by selecting two sections of the tissue within the region of calcium transient 
propagation and dividing the distance between the centres of these regions by the 
difference between their peak maxima.
Direct measurements of force. The force generation was measured directly, using 
an organ bath with high-sensitivity force transducers. Cardiac tissues and FCT 
strips were transferred to a commercial organ bath system (DMT Myograph) con-
taining oxygenated modified Tyrode’s solution (129 mM NaCl, 5 mM KCl, 2 mM 
CaCl2, 1 mM MgCl2, 30 mM glucose, 25 mM HEPES, pH 7.4) supplemented with 
2% B27 and maintained at a constant temperature of 37 °C without electrical stim-
ulation. All measurements were done using LabChart software (ADInstruments). 
The tissues were allowed to equilibrate for 15 min and any spontaneous beating 
measurements were recorded. The tissues were then allowed to equilibrate for 
another 15 min under electrical stimulation (2 Hz, 5 ms, 80–100 mA, rectangular 
pulses) in order to preload the tissues by manual stepwise adjustment of the tissue 
length to that of the maximal force generated, which assumes the optimal sarco-
mere length is thereby attained.
Twitch tension was measured by increasing the organ bath [Ca2+] from 0.2 to 
2.8 mmol/l. Specifically, the extracellular calcium concentration was changed by 
changing the concentration of CaCl2 used in the Tyrode’s solution. The tissues were 
subjected to electrical stimulation for 3 min, and an average of 10 contractions 
were measured. The stimulation was then discontinued for 10, 20 or 30 s, and the 
tissues were allowed to recover for 2 min. Post-rest potentiation measurements 
were subsequently obtained by analysing the change in twitch tension from the 
first beat upon re-initiation of electrical stimulation.
Contractility and twitch parameters were further investigated in response to 
the increasing electrical stimulation frequency within the organ bath as previously 
described25. Twitch forces were calculated as the average of the difference between 
cyclic peak maximum and minimum force and normalized to the cross-sectional 
area (obtained by measurement of tissue at the centre after force measurements). 
The force–frequency relationship was measured by increasing the electrical stimu-
lation frequency from 1 Hz to 6 Hz in 1-Hz increments. The tissues were subjected 
to each stimulation frequency for 30 s before increasing to the next stimulation 
frequency. The force data were measured at frequencies of 1–6 Hz (in 1 Hz incre-
ments) for all experimental groups (static, constant, early-stage and late-stage 
intensity-trained tissues, and human fetal tissue strips) and all iPSC lines.
Continuous recordings of force and calcium as a function of frequency. 
Continuous videos were recorded at a rate of 100 frames per second with a Zyla 4.2 
sCMOS camera (Andor) to determine calcium transients and tissue displacement. 
The stimulation frequency was increased from 1 Hz to 6 Hz in 1-Hz increments 
every 20 s (that is, every 2,000 frames). The calcium transients were analysed using 
custom MATLAB software as described above for measurements of calcium traces, 
and normalized to the baseline at each frequency as (F–F0)/F0. Tissue displacement 
was measured using the Spottracker module in ImageJ. The areas within the tissue 
were manually selected at baseline and tracked frame-to-frame to measure changes 
in the pixel displacement over time. Calcium dye loading was performed as pre-
viously described, but without the use of blebbistatin to block contractile motion. 
This enabled measurements of both calcium transient intensity and displacement 
during calcium imaging.
Immunofluorescent staining. For morphological analysis, tissues and FCTs were 
fixed by using gradually increasing concentrations of paraformaldehyde (1–4%, 
in 1% increments, 1 h each). Whole tissues were paraffin-embedded and cut into 
5-µm-thick sections. The sectioned tissues were quenched in 0.5 M NH4Cl for 
30 min, permeabilized with 0.2% Triton X-100 in PBS for 15 min and then incu-
bated in blocking solution (1% bovine serum albumin (BSA), 2% goat serum in 
PBS) for 2 h. The following primary antibodies were incubated for 2 h in 1% BSA: 
anti-sarcomeric α-actinin (1:200; Abcam ab9465), anti-cardiac troponin T (cTnT, 
1:100; Thermo Scientific MS-295-P1), anti-ryanodine receptor 2 (RYR2, 1:100; 
Abcam ab2827), anti-CaV1.2 (1:200; Abcam ab58552), anti-BIN1 (1:100; Abcam 
ab137459), anti-mitochondria (1:50; Abcam ab3298) and anti-OXPHOS (1:100; 
Acris MS601-720). Actin was deteced with Alexa Fluor 350–phalloidin (Thermo 
Fisher A22281).
Tissues were washed three times for 5 min in 0.2% Triton X-100 and incu-
bated with the corresponding secondary antibodies for 2 h: anti-mouse IgG–Alexa 
Fluor 488 (1:400; Invitrogen A21202), anti-rabbit IgG–Alexa Fluor 568 (1:400, 
Invitrogen, 81-6114) and anti-mouse IgG–Alexa Fluor 635 (1:400, Invitrogen, 
A31574). The tissues were washed and subsequently incubated with NucBlue 
(Molecular Probes, R37606) for nucleus counterstaining. The immunostained 
tissues were visualized using a confocal microscope (Olympus Fluoview FV1000).
For T-tubule immunostaining, tissues were incubated with WGA–Alexa Fluor 
488 (Life Technologies, W11261) or di-8-ANEPPS (Life Technologies, D-3167) for 
20 min before permeabilization and subsequent staining with additional antibodies 
as described above.
Transmission electron microscopy. Tissues, FCTs, and adult heart tissue were 
fixed with 2.5% glutaraldehyde in 0.1 M Sorenson’s buffer (pH 7.2) for 1 h and 
sent to the Electron Microscopy and Histology (EM&H Core) Facility at Weill 
Cornell Medical College for subsequent sample preparation, imaging and data 
interpretation in a blinded fashion. Samples were post-fixed for an additional hour 
with 1% OsO4 in Sorenson’s buffer. After dehydration, the samples were embedded, 
sectioned, stained with toluidine blue and examined under a JEM-1400 electron 
microscope.
Fraction of cells containing sarcomeres. Sectioned tissues were immunofloures-
cently labelled with sarcomeric α-actinin and DAPI. Using the cell counter plugin 
in ImageJ, the DAPI-positive cells were marked and counted. Subsequently, all 
DAPI-positive cells that stained positive for α-actinin were counted, and the per-
centage of cells containing sarcomeres of DAPI-positive cells was calculated.
Sarcomere length. Sarcomere length was determined in dissociated cells that 
were replated as a monolayer and stained with sarcomeric α-actinin by measur-
ing the distance between intensity peaks along the long axis of designated cell areas 
containing clear striations9. A minimum of three sarcomere lengths per cell were 
obtained in large numbers of cells from n > 6 biological replicates.
Change in tissue area. The change in the projected tissue area (per cent change 
between the contracted and relaxed state) was experimentally determined in 
bright light by analysing the change tissues paced at 1 Hz and twice the excitation 
threshold, by custom-designed MATLAB code that used video edge-detection 
based on the contrast between the darker tissue and the lighter surrounding 
area. For each group and time point, the change in area was normalized to the 
change in area measured at day 6, immediately before the application of electrical 
stimulation.
Cell morphology. Cells were enzymatically digested using serial digestions of 
collagenase type 1 and 2 (Worthington), and plated onto eight-well chamber slides 
(Laboratory-Tek, Sigma-Aldrich). The cells were allowed to attach for 72 h and 
imaged using phase-contrast microscopy. Cell area was quantified from the images 
using the ‘%Area’ function in ImageJ after thresholding of the cells in each image. 
Cell elongation ratio was calculated from these images using the ‘Roundness’ func-
tion in ImageJ, in which the aspect ratio was defined as (1 − Roundness), with 0 
corresponding to a circle and 1 corresponding to a completely elongated object30.
RT–PCR. Total RNA was purified from tissues according to the manufacturer’s 
instructions using TRIzol (Life Technologies). For measurements of adult and 
FCT NPPA and NPPB expression, commercial tissues were used: adult heart, ages: 
30–39, pooled from three male hearts (TaKaRa/Clontech Human RNA Master 
Panel II, 636643, lot no. 1208462 A); fetal hearts, GW: 21–37, pooled from 32 male 
and female fetal hearts (Clontech Human Fetal Heart Poly-A+ RNA, 636156, lot 
no. 7110214; synthesized with oligo-dT20 and SSIII kit). Reverse transcription was 
performed using Ready-To-Go You-Prime First-Strand Beads (GE Healthcare, 
27-9264-01) following the manufacturer’s instructions. Gene expression was 
quantified by real-time PCR using SYBR Green primers (Life Technologies) in 
an Applied Biosystems Step One Plus. Data analysis was carried out using the 
log2-fold change normalized to late-stage week 1 tissue gene expression shown 
in Fig. 1b, Extended Data Fig. 2a. Data analysis was carried out using the fold 
change normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene 
expression in Extended Data Fig. 2b, 9c. Primers used are listed in Supplementary 
Information, ‘Primer list’.
Oxygen consumption rate and extracellular acidification rate. Engineered car-
diac tissues were dissociated into single cells after four weeks of cultivation using 
activated papain solution containing 20 U/ml papain (~15 min at 37 °C with gentle 
tapping), as described for electrophysiological recordings. The enzyme reaction 
was terminated by adding 10% FBS in DMEM/F-12 culture medium. The dis-
sociated hiPS-CMs were plated into XF96 Culture Plates (Seahorse Bioscience) 
coated with Matrigel (Corning, 354230) and cultured for three days. Subsequently, 
the plated hiPS-CMs were assayed in real-time using an XF-96 Extracellular Flux 
Analyzer (Seahorse Biosciences) for oxygen consumption rate (OCR) and extra-
cellular acidification rate (ECAR) per the manufacturer’s protocols.
Isoproterenol response. Isoproterenol was diluted in standard medium 
(RPMI + B27) to a concentration of 1 µM. Tissues were placed in the organ bath 
(as previously described) and equilibrated for 10 min. Videos were captured, force 
measurements were recorded before and after addition of the drug, and the change 
in the generated force was determined.
Patch-clamp electrophysiology. Engineered cardiac tissues were dissociated into 
single cells for whole-cell patch-clamp recordings at four weeks using activated 
papain solution containing 20 U/ml papain from Caripa papaya (Sigma-Aldrich 
76220), 1.1 mM EDTA, 67 µM 2-mercaptoethanol (Sigma-Aldrich M3148), 
5.5 mM l-Cysteine-HCl (Sigma-Aldrich C7880) in 1 × EBSS (Thermo Scientific/
Gibco 24010-043). This optimized protocol enabled healthy patchable single 
cardio myocytes to be obtained without spontaneous beating from early-stage 
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intensity-trained cardiac tissues. The same dissociation protocol using papain 
was also used for the other cardiac tissue samples. The tissues were incubated for 
~15 min at 37 °C with gentle tapping, and the enzyme reaction was terminated by 
adding FBS (10%) in DMEM/F-12 culture medium.
Whole-cell patch-clamp recordings of dissociated iPSC-CMs were conducted 
using a patch-clamp amplifier (MultiClamp 700B, Molecular Devices) and an 
inverted microscope equipped with differential interface optics (Nikon, Ti-U). 
Glass pipettes were prepared from borosilicate glass pipettes (Sutter Instrument 
BF150-110-10) and a micropipette puller (Sutter Instrument, Model P-97).
Current-clamp recording for action potential measurements was conducted in 
normal Tyrode’s solution containing 140 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 
10 mM glucose, 1.8 mM CaCl2 and 10 mM HEPES (pH 7.4 with NaOH at 25 °C) 
using the pipette solution 120 mM K d-gluconate, 25 mM KCl, 4 mM MgATP, 2 mM 
NaGTP, 4 mM Na2-phospho-creatine, 10 mM EGTA, 1 mM CaCl2 and 10 mM 
HEPES (pH 7.4 with KCl at 25 °C). Action potentials were stimulated (5 ms, 0.3 nA) 
in a current clamp mode at 37 °C (0.2 Hz), recorded and analysed using Clampfit 
10.4 (Axon Instruments).
Voltage-clamp measurements for IK1 current recording were conducted using 
an extracellular solution containing 160 mM NMDG, 5.4 mM KCl, 2 mM MgCl2, 
10 mM glucose, 10 µM nisoldipine, 1 µM E-4031 and 10 mM HEPES (pH 7.2 with 
HCl at 25 °C) and a pipette solution 150 mM K-gluconate, 5 mM EGTA, 1 mM 
Mg–ATP and 10 mM HEPES (pH 7.2 with KOH at 25 °C). The following pulse 
protocols were used: 2-s voltage clamp applied from −130 to + 10 mV (holding 
at −40 mV, 0.1 Hz, 2-s voltage pulse). The IK1 reversal potential (Ba2+-sensitive 
current) had a negative slope conductance consistent with inward rectification, as 
previously described30. The current–voltage plot was analysed before and after the 
addition of 0.5 mM BaCl2 for 2 min.
Dose–response curves. Drugs were diluted in standard medium (RPMI + B27). 
Successively higher doses of each drug were administered at concentrations of 
10−11 M to 10−5 M, in decigram increments. Videos were captured ≥5 min after 
each dose was administered, and processed using custom image processing soft-
ware as described above. For chronotropic drugs, bright-field videos were taken 
at each drug concentration so that measurements of the beat frequency could be 
determined as a function of drug concentration. For ionotropic drugs, tissues were 
placed in the organ bath and force measurements were recorded as previously 
described at each drug concentration so that the measurements of the change in 
force generated could be determined as a function of drug concentration. Dose–
response curves for these parameters could be constructed by using MATLAB to 
fit the Hill equation for sigmoid curves to the data, to determine the corresponding 
EC50 value.
Paced isoproterenol response. Cardiac tissues were loaded with calcium dye as 
described above. Tissues were transferred to standard medium (RPMI + B27), 
paced at 1 Hz for 30 min to equilibrate, and the baseline video recordings were then 
obtained. Successively higher doses of isoproterenol were administered directly to 
the standard medium at concentrations of 0.01, 100 and 1,000,000 nM. Videos of 
tissues were captured ≥10 min after each dose was administered, and processed 
using custom-designed image analysis software as described above.
Cardiac hypertrophy model. Cardiac tissues were exposed to drugs known to 
induce pathological hypertrophy (angiotensin II, endothelin-1, isoproterenol) on 
day 6 following tissue formation. The first time point (1 week) was taken after 24 h 
of incubation with or without the drug. The majority of the HCM data shown are 
from pathologically induced HCM via endothelin-1 addition (unless data from 
all three drugs are shown), since the results were comparable amongst the three 
HCM-inducing agents.
Statistics and reproducibility. Data are shown as mean ± 95% CI. Differences 
between experimental groups were analysed by one-way or two-way ANOVA. 
Post hoc pairwise analysis was done using Tukey’s HSD test. Electrophysiological 
data were analysed by one-way ANOVA Barlette’s test with multiple comparisons. 
P values < 0.05 were considered significant for all statistical tests. The reproducibility 
of the data are demonstrated by the number of independent biological samples. 
The number of independent experiments performed for each dataset reported 
in the main figures is detailed in Supplementary Information, ‘Main figure data 
sample sizes’. Details of the sample sizes used in the Extended Data are included 
in the respective figure legends.
Reporting Summary. Further information on experimental design is available in 
the Nature Research Reporting Summary linked to this paper.
Code availability. The study used a combination of commercial and open-source 
software packages, which are specified in the Methods, and custom-designed soft-
ware that will be made available to interested investigators upon reasonable request.
Data availability. Source data for quantitative data shown in all figure panels 
are available without restrictions and can be accessed at https://doi.org/10.6084/
m9.figshare.5765559. The detailed experimental protocol is available from Protocol 
Exchange31.
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Extended Data Fig. 1 | Experimental design and overall appearance of 
cardiac tissues. a, Schematic of the pillars (purple) placed via interlocking 
mating components between the bioreactor wells (grey) and pillar lid 
(yellow) with tissues (pink) formed around the pillars, and electrodes 
(black) placed perpendicular to the cardiac tissues. A glass slide (blue) 
is epoxied to the bottom of the bioreactor to enable image acquisition. 
b, A schematic of the assembled bioreactor. c, Photographs of the cardiac 
tissues cultured within the bioreactor. d, The tissue pillar. e, Increase in 
the electrical stimulation frequency throughout the intensity training 
regime. f–h, Photographs of the tissues attached to pillars at the end 
of four-week cultivation: side view (f, g), bottom view (h). Scale bars, 
500 µm. i, j, Immunofluorescence in serial sections of the early-stage 
intensity-trained tissue. The dotted yellow and red lines in g, i, j indicate 
corresponding pillar placement within the tissue. Scale bars, 500 µm. 
k–p, Immunofluorescence in serial sections of the early-stage intensity-
trained tissue in i. WGA, green; α-actinin, pink; nuclei, blue. Scale bars, 
i–l, 500 µm; m, 100 µm; n, 20 µm; o, p, 50 µm. Images were selected to 
include landmark features that facilitate localization and comparisons. 
Similar results were obtained from three independent experiments.
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Extended Data Fig. 2 | Enhanced gene expression and conduction 
in intensity-trained cardiac tissues over time. a, Quantitative gene 
expression in FCTs and C2A iPSC cardiac tissues after two weeks of 
culture, as determined by RT–PCR; shown as fold change relative 
to late-stage tissues at the start of stimulation. b, Quantitative gene 
expression in early-stage cardiac tissues, normalized to GAPDH, from 
three different iPSC lines as determined by RT–PCR after four weeks of 
culture. n = 12 biologically independent samples per group; mean ± 95% 
CI; no significant difference between the cell lines by two-way ANOVA. 
c–f, Representative conduction velocity activation maps for early-stage 
control (c), late-stage intensity-trained (d) and early-stage intensity-
trained (e) cardiac tissues, and surrogate of conduction velocity in early-
stage and late-stage C2A iPSC cardiac tissues after four weeks of culture, 
assessed by calcium propagation (f). Mean ± s.e.m., n = 4–5 biologically 
independent samples per group. g, h, Representative immunofluorescence 
of gap junction (connexin-43 (Cx43), green) expression in early-stage 
intensity-trained iPSC cardiac tissue after four weeks of culture, at low 
(g; scale bar, 10 µm) and high magnification (h; scale bar, 5 µm). cTnT, red; 
nuclei (DAPI), blue. Similar results were obtained from four independent 
experiments.
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Extended Data Fig. 3 | Electrophysiological characterization of  
human engineered cardiomyocytes. a, Representative traces of action  
potentials in early-stage control (n = 9), late-stage intensity-trained  
(n = 9) and early-stage intensity-trained (n = 14) groups. n is the number  
of biologically independent samples obtained during two independent  
experiments. b, Representative traces of IK1 current for the early-stage  
intensity-trained group using voltage-clamp mode. c–f, Electrophysiology 
data after four weeks of culture showing the resting membrane potential (c), 
peak amplitude (d), duration of action potential (e) and upstroke velocity 
(f) obtained in two independent experiments, resulting in biologically 
independent data from early-stage control (n = 9), late-stage intensity-
trained (n = 9) and early-stage intensity-trained (n = 14) groups. 
**P < 0.01, *P < 0.05 using one-way ANOVA Bartlett’s test with multiple 
comparison. n.s., not significant. g–i, Representative continuous organ 
bath force recordings under electrical pacing from 1–6 Hz from three 
biologically independent early-stage intensity trained tissues (C2A cells) 
from one experiment. j, k, Representative continuous recordings from 
an early-stage intensity-trained tissue (C2A cells) under electrical pacing 
from 1–6 Hz of calcium (j) and surrogate force (k) as determined by tissue 
displacement, normalized to 1 Hz.
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Extended Data Fig. 4 | Enhanced maturation and synchronicity of 
cardiac tissues in response to training regime as a function of time. 
a–c, Representative contraction profiles of FCT (a), early-stage (b) and 
late-stage cardiac tissues (c) over time (C2A cell line). d, Frequency 
of contractions in cardiac tissues over four weeks of culture. n = 35 
biologically independent samples over 16 independent experiments; 
mean ± 95% CI, *P < 0.05 compared to control group by two-way 
ANOVA with Tukey’s HSD test. Early-stage intensity-trained tissue 
shows significant differences versus other training regimes by two-
way ANOVA with Tukey’s HSD test. e, Characterization of cardiac cell 
population within cardiac tissues (C2A line) after four weeks of culture by 
fluorescence-activated cell sorting (FACS) analysis. f, g, Characterization 
of cells isolated from early-stage intensity-trained cardiac tissues (C2A 
line) by FACS analysis after four weeks of culture: cardiac cells (f; cTnT), 
and supporting fibroblast cells and endothelial cells (g; vimentin 
and von Willebrand Factor(vWF), respectively). h–j, Representative 
immunofluorescence of whole tissues showing the enhanced cardiac 
ultrastructure (α-actinin, green; cTnT, red; nuclei, blue) in early-stage 
cardiac tissues from the C2A line (h), WTC11 cell line (i), and IMR90 
cell line (j) after four weeks of culture. Scale bars, 5 µm; experiment 
repeated independently 14 times with similar results. k, Representative 
immunofluorescence showing the cell population in a histological section 
from early-stage cardiac tissue (C2A line) after four weeks of culture. cTnT, 
green; vimentin, red; nuclei, blue. Scale bar, 50 µm; experiment repeated 
independently two times with similar results.
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Extended Data Fig. 5 | Physiological hypertrophy within cardiac tissues 
enhances contractility. a–c, Physiological hypertrophy of cardiomyocytes 
cultured in the electromechanically conditioned cardiac tissue format 
increases as a function of time and training regime beyond FCT levels, 
as shown by cell elongation ratio (a) and sarcomere length (b). n = 326 
biological replicates from 15 independent samples in one experiment. 
c, This enables the change in area while being electrically paced at 1 Hz, 
an indirect measure of fractional shortening, to similarly increase beyond 
FCT levels as a function of time and training regime. Data represent the 
ratio of the change in area for a given time point and the change in area at 
day 6. n = 6 biologically independent samples per group; mean ± 95% CI; 
*P < 0.05 compared to FCT group at week four by ANOVA with Tukey’s 
HSD test; line above graph indicates P < 0.05 compared to other training 
regimes by two-way ANOVA with Tukey’s HSD test. d, The enhanced 
cardiac ultrastructure in intensity-trained early-stage cardiac tissues is 
documented by the quantification of sarcomere distribution in cardiac 
tissues. n = 12 biologically independent samples per group, mean ± 95% 
CI. e, f, Representative immunofluorescence of gap junction (connexin-43 
(Cx43), white) in early-stage iPSC cardiac tissue (β-myosin heavy 
chain (β-MHC), green; cTnT, red; nuclei (DAPI), blue) (e) and cardiac 
ultrastructure in early-stage iPSC cardiac tissue (α-actinin, green; cTnT, 
red; nuclei (DAPI), blue) (f) after four weeks of culture. Scale bar, 50 µm; 
experiment repeated independently three times with similar results. 
g, α-Actinin immunofluorescence (white) in cardiac tissues after four 
weeks of culture. Scale bar, 10 µm; experiment repeated independently two 
times with similar results.
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Extended Data Fig. 6 | Enhanced ultrastructural properties of cardiac 
tissues following intensity training. a, Representative transmission 
electron microscopy images for FCTs, adult cardiac tissue, and early-stage 
cardiac tissues (C2A line) using different electromechanical conditioning 
protocols, after four weeks of culture. Scale bar, 500 nm. b, TEM images 
of intensity-trained early-stage cardiac tissues (C2A line) after four weeks 
of culture showing details of various ultrastructural elements, Scale bar, 
500 nm. Similar results to those in a and b were obtained independently 
with the following cells or treatments: FCT (n = 8), adult (n = 2), control 
(n = 3), constant (n = 3), intensity-trained (n = 4).
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Extended Data Fig. 7 | Intensity training of cardiac tissues derived 
from early-stage hiPS-CMs is required to enhance mitochondrial 
development. a, Representative immunofluorescence showing 
ultrastructural proteins WGA (green), α-actinin (red), mitochondria 
(blue) and oxidative phosphorylation (yellow) for early-stage cardiac 
tissues (C2A cell line) at different culture times during exposure to the 
intensity-training electromechanical-conditioning regime. Scale bar, 
20 µm. b, Representative immunofluorescence showing ultrastructural 
proteins WGA (green), α-actinin (red), mitochondria (blue) and oxidative 
phosphorylation (yellow) in cardiac tissues cultured with intensity 
training for four weeks from early-stage hiPS-CMs (C2A cell line), late-
stage hiPS-CMs (C2A cell line) and GW19 FCT. Scale bar, 20 µm. Similar 
results to those in a and b were obtained independently from the following 
experiments: FCT (n = 5), early-stage intensity-trained (n = 3), late-stage 
intensity-trained (n = 3). c, d, Representative TEM images for early-stage 
(c) and late-stage cardiac tissues (d) (C2A cell line) after two weeks of 
exposure to the intensity-training electromechanical-conditioning regime. 
Scale bar, 1 µm; experiment not repeated independently.
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Extended Data Fig. 8 | Formation of T-tubules in early-stage intensity-
trained cardiac tissues. a–e, Axial tissue cross-sections from intensity-
trained cardiac tissues (C2A line) after four weeks of culture showing 
T-tubules (WGA, green) and nuclei (DAPI, blue) at low magnification 
(a; scale bar, 100 µm), medium magnification (b and c; scale bar, 10 µm) 
and high magnification (d and e; scale bar, 5 µm). f, g, Axial tissue cross-
sections showing T-tubules (WGA, green), actin (red) and DAPI (blue) in 
intensity-trained cardiac tissues (C2A line) after four weeks of culture (f)  
and GW19 FCT (g). Scale bar, 10 µm. h, Immunofluorescence of paraffin-
embedded and sectioned cardiac tissues from three different iPSC cell 
lines (C2A, WTC11, IMR90) after four weeks of intensity training showing 
the formation of T-tubules (confirmed by both WGA staining and  
di-8-ANEPPS staining), and striated ultrastructure (actin). Scale bar, 
10 µm. Similar results to those in a–h were obtained in a minimum of four 
independent experiments.
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Extended Data Fig. 9 | See next page for caption.
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Extended Data Fig. 9 | Intensity training upregulates cardiac 
maturation in early-stage tissues through enhanced calcium handling. 
a, b, Intensity training promotes T-tubule formation in early-stage 
hiPS-CM tissues, as demonstrated by immunofluorescence of ryanodine 
2 receptor (RYR2, green), bridging integrator 1 (BIN1, blue) and T-tubule 
staining (di-8-ANEPPs, red). Scale bar, 10 µm. c, Expression of ATP2A2 
and SLC8A1 genes, which are responsible for maintaining proper calcium 
homeostasis, in early-stage tissues as determined by RT–PCR and 
normalized to GAPDH over four weeks of culture with the designated 
stimulation regime. Independent biological replicates per group: FCT, 
n = 8; control, n = 6; constant, n = 6; intensity-trained, n = 14; adult, n = 1. 
Mean ± 95% CI, *P < 0.05 versus FCT group at week four by ANOVA 
with Tukey’s HSD test. Line over graph indicates P < 0.05 compared 
to other training regimes by two-way ANOVA with Tukey’s HSD test. 
d, Relaxation times in early-stage tissues as characterized by the full-width 
half-maximum (FWHM) values and the decay time (90% of the time 
from the maximal peak of the calcium transient). Independent biological 
replicates per group: FCT, n = 8; C2A, n = 12; WTC11, n = 6; IMR90, 
n = 6. Mean ± 95% CI; *P < 0.05 versus FCT group by ANOVA with 
Tukey’s HSD. Line over graph indicates P < 0.05 between cell lines by two-
way ANOVA. e, Representative calcium traces of early-stage tissues treated 
with 1 µM nifedipine. f, g, Representative traces of calcium release after 
stimulation with 5 mM caffeine in early-stage tissues and FCTs treated 
with 1 mM verapamil (f) or 2 µM thapsigargin (g). h, Representative traces 
of calcium release after stimulation with 5 mM caffeine for early-stage 
tissues and FCTs. i, Calcium spikes detected by fluorescent calcium dyes 
in early and late-stage tissues (C2A line) after four weeks of culture at 
two calcium concentrations. j, Intensity-trained early-stage but not late-
stage tissues (C2A line) after four weeks of culture respond to ryanodine 
(1 µmol l−1). k, The force–frequency relationship of early-stage intensity-
trained cardiac tissues (C2A line) after four weeks of culture, treated with 
the RYR2 blocker ryanodine (1 µM) or the SERCA2a blocker thapsigargin 
(1 µM). Directly measured force data; n = 13 biologically independent 
samples for intensity group and n = 3 biologically independent samples for 
other groups. Mean ± 95% CI, line over graph indicates P < 0.05 by two-
way ANOVA.
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Extended Data Fig. 10 | Intensity training in early-stage tissues 
enables physiologically relevant drug responses and the development 
of a pathological hypertrophy disease model. a, b, Calcium intensity 
measurements (a) and relaxation time obtained by measuring the time 
from the peak to 90% of the relaxation (R90) during electrical pacing (b) at 
1 Hz in early-stage intensity-trained tissues (C2A line) after four weeks of 
culture with increasing doses of isoproterenol. n = 20 biological replicates 
from six independent experiments. Mean ± 95% CI; *P < 0.05 versus 
baseline response by ANOVA with Tukey’s HSD test. c, Cell area over four 
weeks of culture for the designated stimulation regime. n = 10 biological 
replicates from five independent experiments. Mean ± 95% CI; line above 
graph indicates P < 0.05 compared to other training regimes by two-way 
ANOVA with Tukey’s HSD test. d, Frequency of contractions in healthy 
(C2A) and hypertrophic (HCM) heart tissues over four weeks of culture. 
n = 12 independent biological samples from five independent experiments. 
Mean ± 95% CI. e, Relaxation times in early-stage tissues (C2A line) and 
early-stage hypertrophy tissues (HCM) as characterized by FWHM values 
and the decay time (90% of the time from the maximal peak of the calcium 
transient). n = 20 biological replicates from four independent experiments. 
Mean ± 95% CI; line above graphs indicate P < 0.05 compared to other 
training regimes by two-way ANOVA with Tukey’s HSD test. f, Early-stage 
intensity-trained hypertrophy tissues exhibit impaired FDAR, as shown for 
each stimulation frequency by individual traces of calcium peaks.
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?    Experimental design
1.   Sample size
Describe how sample size was determined. Initial sample size per experiment was determined based on preliminary studies, and were 
different for different types of assays, as necessary to achieve statistical significance of data. 
Statistical methods were not used to predetermine sample size. Instead, sample sizes were 
chosen to include a minimum of n=3 independent biological replicates per experiment, and 
multiple independent experiments were performed. To further verify the experimental 
results, the experiments were repeated using three iPS cell lines from three different donors.
2.   Data exclusions
Describe any data exclusions. No data were excluded from the analyses.
3.   Replication
Describe the measures taken to verify the reproducibility 
of the experimental findings.
A total of 253 independently grown cardiac tissues were analyzed, with 12-94 tissues per 
experimental group, and excellent reproducibility of the experiments.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Engineered tissues were randomly allocated into the experimental groups
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
The investigators as well as the facilities providing specific analytical assessments were 
blinded to experimental group allocation. 
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present 
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
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?   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
All software packages used in the study (e.g., for the measurements of force, contractility, 
and calcium responses) is specified in the Methods. The commercial or open source software 
included LabChart 8, Matlab 2014b, and GraphPad Prism 5. The custom-developed software 
will be made available to other investigators if requested. 
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
?   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a third party.
There are no restrictions, all materials used in the study are available.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
All antibodies and their sources are specifically described in the table within the 
"Immunofluorescent staining" section of the Methods.
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. Three lines of human induced pluripotent stem cells (iPS cells) were used in the experiments. 
These cell lines were obtained through Material Transfer Agreements from Stephen Duncan, 
University of Wisconsin (C2A line), Bruce Conklin, Gladstone Institute (WT11 line) and 
Masayuki Yazawa, Columbia University (IMR90 line).
b.  Describe the method of cell line authentication used. All iPS lines we have used are well characterized and published. The autheticity of these lines 
and their derivatives (iPS-cardiomyocytes) were further confirmed by monitoring marker 
expression and conducting functional assays. This was also the method for assuring 
reproducibility of the experiments over 4 years of duration of the study.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
The cells were regularly tested for mycoplasma (by PCR) and karyotype.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cells were used.
?    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide all relevant details on animals and/or 
animal-derived materials used in the study.
No animals were used.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
There were no human research participants in the study. 
